Position in LLY
as of Mar 31, 2026
· filed May 8, 2026
Position Value
$47,210,789,709
-$7,956,000,289 QoQ
Shares Held
51,328,908
-0.0% QoQ
Ownership
5.45%
of shares outstanding
% of Portfolio
40.85%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Mar 2020
25 quarters on record
Voting authority
Sole 2.524906627664863.ToString("F0")%
Shared 97.4237928459339.ToString("F0")%
None 0.05130052640122404.ToString("F0")%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Mar 31, 2026PNC FINANCIAL SERVICES GROUP, INC. holds $51,364,425,965 across 16 Drug Manufacturers - General names. LLY ranks #1 (91.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
51,328,908 | $47,210,789,709 | |
| 2 | JNJ |
Johnson & Johnson
|
5,752,985 | $1,406,259,649 | |
| 3 | MRK |
Merck & Co., Inc.
|
7,530,441 | $905,836,743 | |
| 4 | ABBV |
AbbVie Inc.
|
4,114,966 | $894,963,949 | |
| 5 | AMGN |
Amgen Inc
|
1,073,540 | $377,725,045 | |
| 6 | BMY |
Bristol Myers Squibb Co
|
3,379,304 | $204,954,785 | |
| 7 | PFE |
Pfizer Inc
|
6,971,622 | $195,763,142 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
486,271 | $67,771,586 |
All Filings in LLY
Export CSV
25 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $47,210,789,709 | 51,328,908 | Shares | Defined | 2026-05-08 | |
| 2025-12-31 | $55,166,789,998 | 51,333,220 | Shares | Defined | 2026-02-06 | |
| 2025-09-30 | $39,190,876,207 | 51,364,189 | Shares | Defined | 2025-11-07 | |
| 2025-06-30 | $39,985,196,226 | 51,293,980 | Shares | Defined | 2025-08-08 | |
| 2025-03-31 | $83,669,349,386 | 101,305,650 | Shares | Defined | 2025-05-09 | |
| 2024-12-31 | $39,605,992,428 | 51,303,099 | Shares | Defined | 2025-02-07 | |
| 2024-09-30 | $45,502,525,133 | 51,360,730 | Shares | Defined | 2024-11-08 | |
| 2024-06-30 | $46,540,910,413 | 51,404,836 | Shares | Defined | 2024-08-09 | |
| 2024-03-31 | $40,016,858,955 | 51,438,196 | Shares | Defined | 2024-05-10 | |
| 2023-12-31 | $30,142,485,997 | 51,709,473 | Shares | Defined | 2024-03-22 | |
| 2023-09-30 | $27,817,581,870 | 51,789,291 | Shares | Defined | 2023-11-13 | |
| 2023-06-30 | $24,325,901,145 | 51,869,805 | Shares | Defined | 2023-08-11 | |
| 2023-03-31 | $17,831,032,633 | 51,921,940 | Shares | Defined | 2023-05-15 | |
| 2022-12-31 | $19,036,895,235 | 52,036,123 | Shares | Other | 2023-02-10 | |
| 2022-09-30 | $16,827,166,979 | 52,040,102 | Shares | Defined | 2022-11-10 | |
| 2022-06-30 | $16,889,815,743 | 52,092,082 | Shares | Defined | 2022-08-12 | |
| 2022-03-31 | $14,933,011,070 | 52,145,864 | Shares | Defined | 2022-05-12 | |
| 2021-12-31 | $14,395,469,087 | 52,115,955 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $12,042,810,274 | 52,122,096 | Shares | Defined | 2021-11-05 | |
| 2021-06-30 | $11,981,860,009 | 52,203,991 | Shares | Defined | 2021-08-06 | |
| 2021-03-31 | $9,753,658,099 | 52,208,854 | Shares | Defined | 2021-05-07 | |
| 2020-12-31 | $8,835,987,459 | 52,333,496 | Shares | Defined | 2021-02-12 | |
| 2020-09-30 | $348,620,993 | 2,355,229 | Shares | Defined | 2020-11-06 | |
| 2020-06-30 | $393,242,289 | 2,395,190 | Shares | Defined | 2020-08-28 | |
| 2020-03-31 | $340,142,686 | 2,452,009 | Shares | Defined | 2020-05-08 | |
| No filing history on record for this holder in this stock. | ||||||